DBV Technologies
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch DBVT and buy or sell other stocks, ETFs, and their options commission-free!About DBVT
DBV Technologies SA is a clinical-stage biopharmaceutical company, which engages in the research and development of epicutaneous immunotherapy products. The firm focuses on the development of Viaskin, an electrostatic patch, which may offer a convenient, self-administered, and non-invasive immunotherapy to patients.
CEODaniel Tassé
CEODaniel Tassé
Employees109
Employees109
HeadquartersChatillon, Hauts-de-France
HeadquartersChatillon, Hauts-de-France
Founded2002
Founded2002
Employees109
Employees109
DBVT Key Statistics
Market cap375.01M
Market cap375.01M
Price-Earnings ratio-2.30
Price-Earnings ratio-2.30
Dividend yield—
Dividend yield—
Average volume106.64K
Average volume106.64K
High today$13.94
High today$13.94
Low today$13.27
Low today$13.27
Open price$13.81
Open price$13.81
Volume141.38K
Volume141.38K
52 Week high$14.44
52 Week high$14.44
52 Week low$2.20
52 Week low$2.20
Analyst ratings
83%
of 6 ratingsBuy
83.3%
Hold
0%
Sell
16.7%